Cargando…
Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies
Vaccines and immunotherapies involve a variety of technologies and act through different mechanisms to achieve a common goal, which is to optimize the immune response against an antigen. The antigen could be a molecule expressed on a pathogen (e.g., a disease-causing bacterium, a virus or another mi...
Autor principal: | Dobrovolskaia, Marina A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943637/ https://www.ncbi.nlm.nih.gov/pubmed/31861154 http://dx.doi.org/10.3390/molecules24244620 |
Ejemplares similares
-
The Recognition of and Reactions to Nucleic Acid Nanoparticles by Human Immune Cells
por: Bila, Dominika, et al.
Publicado: (2021) -
Change in Lipofectamine Carrier as a Tool to Fine-Tune Immunostimulation of Nucleic Acid Nanoparticles
por: Newton, Hannah S., et al.
Publicado: (2023) -
Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells
por: Hong, Enping, et al.
Publicado: (2019) -
Induction of Cytokines by Nucleic Acid Nanoparticles (NANPs) Depends on the Type of Delivery Carrier
por: Avila, Yelixza I., et al.
Publicado: (2021) -
Nucleic acid delivery and nanoparticle design for COVID vaccines
por: Andresen, Jason L., et al.
Publicado: (2021)